Literature DB >> 31596635

Recurrence of Immune-Mediated Colitis Upon Immune Checkpoint Inhibitor Resumption: Does Time Matter?

Julie Delyon1, Nelson Lourenço1, Lan-Trang Vu1, Clara Allayous1, Barouyr Baroudjian1, Celeste Lebbe1.   

Abstract

Entities:  

Year:  2019        PMID： 31596635     DOI： 10.1200/JCO.19.01891

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Safety and Efficacy of the Rechallenge of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer: A Systemic Review and Meta-Analysis.

Authors:  Qing Zhao; Jianwei Zhang; Lingyi Xu; Huaxia Yang; Naixin Liang; Li Zhang; Fengchun Zhang; Xuan Zhang
Journal:  Front Immunol       Date:  2021-09-27       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.